Back to Screener

Healthcare

CG Oncology, Inc.(CGON)

Live Price

Offline

$69.76

-4.23% today

1Y Change

+164.82%

Window

Jun 27, 2025 β†’ Jun 24, 2026

Market Cap
$5.67B
Revenue Growth
+254.7%
EPS Growth
-47.5%
Dividend Yield
0.0%

Coverage: 248 bars Β· Jun 27, 2025 β†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

CG Oncology, Inc. (CGON) is a Healthcare stock with a market cap of $5.67B and listed on NASDAQ. The stock last traded around $69.76 and up 164.8% across the available one-year price window (Jun 27, 2025 β†’ Jun 24, 2026). Baseline metrics include revenue growth of +254.7%, EPS growth of -47.5%, a dividend yield of 0.0%. What stands out right now is revenue +254.7%, EPS -47.5%, free cash flow -67.8% with operating margin -4722.1% and ROIC -25.0%. Valuation already assumes a fairly strong business story at price/sales 1403.9. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CGON price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CGON vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CGON

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CGON Max Drawdown

-27.41%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CGON and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

πŸ“… Last reportedMay 7, 2026
PeriodB/MEPSEPS Ξ”RevenueRev Ξ”Report
β€”
May 7, 26
β€”
Est -0.58
β€”
β€”
Est 452.7B
β€”
May 7
β€”
Feb 27, 26
βœ“
-0.51
Est -0.61
+16.4%
2300.0B
Est 450.5B
+410.5%
Feb 27
β€”
Nov 14, 25
βœ—
-0.57
Est -0.56
-2.0%
1666.0B
Est 59.4B
+2706.4%
Nov 14
β€”
Aug 8, 25
βœ—
-0.54
Est -0.49
-10.2%
β€”
Est 81.6B
β€”
Aug 8
β€”
May 13, 25
βœ—
-0.45
Est -0.39
-15.4%
52.0B
Est 118.2B
-56.0%
May 13
β€”
Mar 28, 25
βœ—
-0.48
Est -0.41
-17.1%
456.0B
Est 124.0B
+267.9%
Mar 28
β€”
Nov 14, 24
β€”
Est -0.42
β€”
β€”
Est β€”
β€”
Nov 14
β€”
Aug 8, 24
βœ“
-0.28
Est -0.42
+33.3%
111.0B
Est β€”
β€”
Aug 8
β€”
May 9, 24
βœ—
-0.36
Est -0.35
-2.9%
529.0B
Est β€”
β€”
May 9
β€”
Mar 26, 24
β€”
Est -0.67
β€”
β€”
Est β€”
β€”
Mar 26
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the market calendar